DalsnaFinance › Analyst accuracy › RBC Capital Markets › JNJ target
RBC Capital raises Johnson & Johnson stock price target on pharma strength
RBC Capital raised its price target on Johnson & Johnson shares (NYSE:JNJ) to $290 from $287 while maintaining an Outperform rating.
A fact about what RBC Capital Markets published, as reported by Investing.com, not a recommendation from Dalsna Finance; RBC Capital Markets is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.